This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2001:44:349-56.

doi: 10.1016/s0065-2660(01)44091-0.

Future perspectives for Tay-Sachs disease

R J Desnick¹, M M Kaback

Affiliations

PMID: 11596996
DOI: 10.1016/s0065-2660(01)44091-0

Review

Future perspectives for Tay-Sachs disease

R J Desnick et al. Adv Genet. 2001.

. 2001:44:349-56.

doi: 10.1016/s0065-2660(01)44091-0.

Authors

R J Desnick¹, M M Kaback

Affiliation

¹ Department of Human Genetics, Mount Sinai School of Medicine of New York University, New York 10029, USA.

PMID: 11596996
DOI: 10.1016/s0065-2660(01)44091-0

No abstract available

PubMed Disclaimer

Similar articles

Lessons from the American Tay-Sachs Programme.
Steele MW. Steele MW. Lancet. 1980 Oct 25;2(8200):914. doi: 10.1016/s0140-6736(80)92069-3. Lancet. 1980. PMID: 6107561 No abstract available.
Screening for carriers of Tay-Sachs disease: two approaches.
Clarke JT. Clarke JT. Can Med Assoc J. 1978 Sep 23;119(6):549-50. Can Med Assoc J. 1978. PMID: 709442 Free PMC article. No abstract available.
Carrier screening for Tay-Sachs.
Ellis I. Ellis I. Nursing (Lond). 1991 Sep 12-25;4(41):16-8. Nursing (Lond). 1991. PMID: 1945106 No abstract available.
Neuropsychiatric aspects of the adult variant of Tay-Sachs disease.
MacQueen GM, Rosebush PI, Mazurek MF. MacQueen GM, et al. J Neuropsychiatry Clin Neurosci. 1998 Winter;10(1):10-9. doi: 10.1176/jnp.10.1.10. J Neuropsychiatry Clin Neurosci. 1998. PMID: 9547461 Review.
Tay-Sachs disease.
Gelbart M. Gelbart M. Nurs Times. 1998 Mar 18-24;94(11):39. Nurs Times. 1998. PMID: 9697531 Review. No abstract available.

See all similar articles

Cited by

Lipid-Lowering Drug Gemfibrozil Protects Mice from Tay-Sachs Disease via Peroxisome Proliferator-Activated Receptor α.
Raha S, Dutta D, Paidi RK, Pahan K. Raha S, et al. Cells. 2023 Dec 8;12(24):2791. doi: 10.3390/cells12242791. Cells. 2023. PMID: 38132111 Free PMC article.
Cinnamic acid, a natural plant compound, exhibits neuroprotection in a mouse model of Sandhoff disease via PPARα.
Raha S, Paidi RK, Dutta D, Pahan K. Raha S, et al. NeuroImmune Pharm Ther. 2024 Mar 15;3(1):17-32. doi: 10.1515/nipt-2023-0027. eCollection 2024 Mar. NeuroImmune Pharm Ther. 2024. PMID: 38532783 Free PMC article.
High school Tay-Sachs disease carrier screening: 5 to 11-year follow-up.
Curd H, Lewis S, Macciocca I, Sahhar M, Petrou V, Bankier A, Lieberman S, Levy-Lahad E, Delatycki MB. Curd H, et al. J Community Genet. 2014 Apr;5(2):139-46. doi: 10.1007/s12687-013-0163-z. Epub 2013 Jul 27. J Community Genet. 2014. PMID: 23893770 Free PMC article.
Lysosomal Diseases and Neuropsychiatry: Opportunities to Rebalance the Mind.
Cox TM. Cox TM. Front Mol Biosci. 2020 Aug 26;7:177. doi: 10.3389/fmolb.2020.00177. eCollection 2020. Front Mol Biosci. 2020. PMID: 33005626 Free PMC article.
Three novel mutations in Iranian patients with Tay-Sachs disease.
Jamali S, Eskandari N, Aryani O, Salehpour S, Zaman T, Kamalidehghan B, Houshmand M. Jamali S, et al. Iran Biomed J. 2014;18(2):114-9. doi: 10.6091/ibj.1137.2013. Iran Biomed J. 2014. PMID: 24518553 Free PMC article.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

LinkOut - more resources

Medical
- MedlinePlus Health Information